Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute Graft-vs-host disease: 6-month follow-up data from the phase 2 REACH1 trial
BONE MARROW TRANSPLANTATION(2019)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined